Skip to content

Heart Rate Variability in Extracorporeal Membrane Oxygenation (ECMO) Patients

Clinical Application of Multimodal Physiological Signal Analysis in Critical Ill Patients Depending on Extracorporeal Membrane Oxygenation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01247727
Enrollment
40
Registered
2010-11-24
Start date
2011-07-31
Completion date
2012-12-31
Last updated
2011-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Rate Variability

Keywords

Heart rate variability, extracorporeal membrane oxygenation

Brief summary

National Taiwan University Hospital is the leading center for care of patients with extracorporeal membrane oxygenation (ECMO). The predictable factors associated with outcomes are still lacking in patients with the ECMO support. The aim of this study is to collect the electrical signals stored in the monitor of intensive care units (ICUs), which are analyzed by the bio-informatics software. The pre-, peri-, and post-ECMO heart rate variability, including linear and non-linear analysis is calculated to address the association with outcomes of patients with ECMO. In addition, we collected the demographics, body temperature, respiratory rate, and blood pressure to investigate the causes of heart rate variability.

Detailed description

Inclusion criteria:Adults patients (aged older than 18 years; less than 90 years old) used ECMO for cardiopulmonary support Exclusion criteria: 1. Patients used illicit drugs 2. Patients received heart transplantation 3. Patients have the history of arrhythmia

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults patients (aged \> 18 years; less than 90 years old) used ECMO for cardiopulmonary support

Exclusion criteria

* Patients used illicit drugs * Patients received heart transplantation * Patients have the history of arrhythmia

Countries

Taiwan

Contacts

Primary ContactJin-Ming Wu, M.D.
kptkptkpt@yahoo.com.tw886-0972653213

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026